Scar Dressings Market - Forecast(2024 - 2030)

Scar Dressings Market Overview

Scar Dressings Market Size is estimated to reach $894.3 million by 2027. Furthermore, it is poised to grow at a CAGR of 14.1% over the forecast period of 2022-2027. The scar is an area of fibrous tissue that replaces normal skin after an injury. Scars form as a result of the body's organic wound-healing process in the skin, as well as other organs and tissues. Scar dressings are commonly used to enhance the look of hypertrophic and keloid scars while also preventing scar development. After surgical treatment, a severe injury, or burns, a scar develops. After surgery, scarring can cause disability and deformity. Furthermore, stretch marks and pregnancy scars occur on the skin that has an off-color or reddish-purple appearance. Stretch marks, also known as striae, are a type of scarring that occurs in both girls and boys as a result of weight loss throughout adolescence. A sterile pad is a thin piece of a cloth-like material used to protect open wounds and scars from bacteria. Also, iodopovidone is commonly used for scars and wounds. According to the Population Reference Bureau published in 2019, around 50 million people are wounded in road accidents each year, resulting in scarring that needs surgical treatment. Patients who have such surgeries also develop surgical scars, which are treated with topical treatments to improve and decrease their appearance, boosting the market growth. Increased demand for sterile pads to stop the flow of blood and treat the wound area using disinfectants, rising demand for iodopovidone to sanitize healthcare professionals' hands, and expanding investment by major competitors to develop enhanced scar dressings are some of the factors driving Scar Dressings Market growth during the forecast period 2022-2027.

Scar Dressings Market Report Coverage

The report: “Scar Dressings Market Forecast (2022-2027)", by Industry ARC covers an in-depth analysis of the following segments of the Scar Dressings Market.

Key Takeaways

• Geographically, North America held a dominant market share in the year 2021 on account of the increasing prevalence of psoriasis arthritis, highly informed people knowing the benefits of Scar Dressings, and high healthcare expenditure. Asia-Pacific is expected to offer lucrative growth opportunities to the manufacturers owing to the increasing prevalence of Crohn's disease and ulcerative colitis. 

• Increasing demand for better healthcare facilities as well as the boost in the investments done by government and private companies in the pharma industry is fueling the market growth. The proliferation of Rheumatoid arthritis is predicted to further augment the market growth during the forecast period of 2022-2027.

• The key factors driving the growth of scar dressings are the growing prevalence of arthritis and skin disorders. However, the high cost, as well as side effects of Scar Dressings poses threat to the market growth.

• A detailed analysis of strengths, weaknesses, opportunities, and threats will be provided in the Scar Dressings Market Report.

 Scar Dressings Market: Market Share (%) by region, 2021

For more details on this report - Request for Sample

Scar Dressings Market Segmentation Analysis- By Product type

Scar Dressings Market based on product type can be further segmented into Sterile Dressings and Non-sterile Dressings. Sterile Dressings held a dominant market share in the year 2021 and is estimated to be the fastest-growing, with a CAGR of 15.7% over the forecast period of 2022-2027. This expansion can be attributed to causes such as the increased use of sterile pads and the rising need for microorganism-free sterile dressings. Furthermore, therapy with these products does not need individuals to visit physicians for medicine; as a result, it is a more convenient option, which is likely to increase demand for these products. The expansion of the segment is being further fueled by increasing expenditures by major players in research and development efforts for creating better sterile dressings. Owing to circumstances such as the rising incidence of stretch marks and the growth in product releases by major players, the Non-sterile Dressings category had the second biggest market in 2021.

Scar Dressings Market Segmentation Analysis- By End User

Scar Dressings Market based on end user can be further segmented into Hospitals, Community Centers, and Others. The hospital’s segment held a dominant market share in the year 2021 owing to factors such as increased adoption of sterile dressings for the treatment of hypertrophic scars in hospitals. According to WHO, burning is a global public health issue that kills an estimated 180,000 people each year. The vast majority occur in low- and middle-income countries, with about two-thirds in the WHO African and Southeast Asia areas. Moreover, increased investment by key companies to develop enhanced scar dressings for the treatment of diverse scars in hospitals is enhancing segment growth.

The Community Centers segment is estimated to be the fastest-growing segment with a CAGR of 15.9% over the forecast period 2022-2027. This growth is attributed to factors such as increased demand for sterile pads for treating open wounds in community centers and increased patient knowledge of scar therapy in community centers.

Scar Dressings Market Segmentation Analysis- By Geography

The Scar Dressings Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held a dominant market share of 34% in the year 2021 as compared to the other counterparts on account of the rise in the occurrence of stretch marks as a result of rapid weight fluctuations. Moreover, according to the data given by BMC, it is estimated that 1 to 2% of the population experience chronic wounds in developed countries, and this number is enhanced with the increase in the aging population thus requiring sterile pads for scar dressing. Further, an increase in product releases by major competitors is driving this segment's growth. 

However, Asia-Pacific is estimated to be the fastest-growing over the forecast period of 2022-2027 on account of the growing demand for sterile pads to stem the flow of blood and treat the wound region using disinfectants. Further, rising investment by major companies to create enhanced scar dressings, is driving regional expansion.

Scar Dressings Market Drivers

Growing consumption of Sterile Pads Enhances The Market Growth.

The market for scar dressing is expected to grow owing to an increase in the number of burns, trauma events, and road accidents around the world. According to the World Health Organization report published in 2019, over 1,000,000 persons in India suffer from severe or moderate burns each year. For open wounds, sterile pads are increasingly being utilized to stop the flow of blood and sanitize the wound region. These sterile pads are also utilized as dressings in the outpatient department for minor operations for the main treatment of infected and extremely exudative wounds, which is fueling the growth of the market. Each year an estimated 180,000 deaths are caused by burns and injuries in the body as per data revealed by World Health Organization. Moreover, sterile pads which have sustainable fibers mixed with spill lock technology gain greater traction in the market. Hence, an Increasing Number of Sterile Pads is estimated to drive the industry expansion.

The rising Prevalence of Hypertrophic Scars drives the market growth.

Sterile dressings and sterile pads for cushioning and cleaning at the risk of injection are in high demand owing to the increased occurrence of hypertonic scars as a result of the increasing number of skin injuries. One of the primary reasons driving the growth of the Scar Dressings Market is the emphasis of key players in developed countries on creating enhanced sterile pads for the treatment of hypertonic scars. According to research published in MEDLINE, in 2019, 110 burn survivors were recorded and all hypertrophic scars of all sizes and places were counted in all races, with the frequency of hypertrophic scarring being 67%. Also, Sonoma Pharmaceuticals, Inc., for instance, announced an asset purchase agreement with Middle East partner MicroSafe Group in February 2020. MicroSage Group agreed to sell Sanoma Pharmaceuticals various wound care, disinfection, and animal health care products in Australia, Europe, and the Middle East for USD 1.1 million. As a result of various strategies employed by prominent market competitors, hypertrophic therapy is expected to gain traction throughout the forecast period.

Scar Dressings Market Challenges

The growing availability of substitute products impedes the market growth.

The market's major players are working with one another to conduct various research and development efforts in order to release enhanced scar dressing products for the treatment of a variety of scars. However, one of the primary reasons estimated to slow the growth of the Scar Dressings Market is the increased availability of replacement products for scar therapy affecting around 4-5% of product sales as per the NCBI report launched in 2019. For instance, Silicone therapy is an attractive alternative to more invasive treatment options as it is easy to use. Also, factors related to the wound (surface, volume, damage to the noble tissues, misdiagnosis of the aetiology of the wound, and lack of diagnosis of infectious or ischemic complications of the wound) as well as factors related to environmental or social difficulties in terms of resources available for wound treatment are posing a threat to market growth.

Scar Dressings Industry Outlook

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Scar Dressings Market. The top 10- Scar Dressings Market companies are-

1. Medtronic plc.
2. Alliqua BioMedical
3. Smith and Nephew plc.
4. Acelity L.P. Inc.
5. BSN Medical GmbH
6. 3M Company
7. Integra LifeSciences Holdings Corporation
8. Coloplast A/S
9. AxioBiosolutions
10. Mlnlycke Health Care AB

Recent Developments

• In December 2020, Coloplast A/S launched Biatain Fiber, the novel gelling fiber Biatain Fiber with HexaLock Technology is for all strongly oozing, sloughy, and cavity wounds, including undermining. Exudate and bacteria are efficiently absorbed and retained, preventing exudate pooling. It also maintains its structure, reducing the likelihood of gaps and additional exudate pooling. Diabetic ulcers, leg ulcers (arterial ulcers, venous ulcers, and mixed etiology leg ulcers), pressure injury (stage II-IV), exudate absorption in oncology wounds, traumatic wounds, partial-thickness burns, donor sites, and post-operative surgical wounds are among the conditions for which Biatain Fiber is indicated.

• In December 2020, Integra LifeSciences Holdings Corporation acquired ACell, Inc, for a $300 million upfront cash payment at closure, subject to usual acquisition price modifications, and up to an additional $100 million in cash payments based on the attainment of specified revenue growth objectives. ACell is a regenerative medicine firm with a product line based on MatriStem UBMTM, a patented porcine urinary bladder matrix platform technology.

• In April 2020, AxioBiosolutions launched MaxioCel, this advanced wound care dressing is based on bioactive microfiber gelling technology that accelerates healing through quicker granulation. It also provides comfort and shows fast healing on chronic wounds such as pressure ulcers, diabetic wound ulcers, venous leg ulcers, cavity wounds, skin abrasions, donor sites, and post-operative surgical wounds.

Relevant Titles